de Garidel Marc - Insider Non-Derivative Transactions at CinCor Pharma, Inc. (CINC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 24, 2023, de Garidel Marc's relationship to CinCor Pharma, Inc. (CINC) is Director,Officer (Chief Executive Officer), and currently has 200,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CINC insiders.
Data Source: SEC.
de Garidel Marc - Insider Non-Derivative Transactions of CINC Common Stock
de Garidel Marc - Insider Non-Derivative Transactions at CINC
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Feb 25, 2023 | Disposition -- (Common Stock) | 200000 | 0 | 0 |
Feb 25, 2023 | U -- (Common Stock) | 12500 | 0 | 200000 |
Jan 27, 2023 | Acquisition -- (Common Stock) | 200000 | 0 | 212500 |